Rezultati pretraživanja
  1. . published first on in 2000 covering both and . Since these conditions require different treatment strategies, the first was produced in 2004 and now updated every year based on and

  2. prije 3 sata

    We devised, made and seeded this in recent days. This way not only my personal life is dominated by this awful disease 🙍‍♂️

    Prikaži ovu nit
  3. prije 4 sata

    Παγκόσμια ημέρα καρκίνου Η Ευρωπαϊκή Ουρολογική Εταιρεία επικαιροποιεί κάθε χρόνο τις κατευθυντήριες γραμμές για τους ουρολογικούς καρκίνους

  4. 3 urological cancers are among the top 10 most common cancers in Europe: Prostate, Bladder and Kidney. Every person matters. Every action counts. That is why we constantly update the EAUguidelines. ▶️

  5. 3. velj

    What have been studied for treatment of benign prostatic obstruction in the past 20 years? Rise and fall of multiple therapies summarized - available at

  6. Assess the response to testosterone treatment at 3, 6 and 12 months after the onset, and thereafter annuall.

  7. 2. velj

    always working!!! Even on sundays!!! Just for being released on time and help all of us with our patients management!!

  8. Proposed surveillance schedule following treatment for RCC, taking into account patient risk profile and treatment efficacy.

  9. 30. sij
    Odgovor korisnicima

    As we are practically living in (like the film attached from or any is reality here, unlike elsewhere. This is why apply to us apply to us.

  10. Perform surgical orchidolysis and orchidopexy before 12 m, and 18 m. at the latest.

  11. With fever or solitary kidney and when diagnosis is doubtful immediate imaging is indicated.

  12. From our guidelines office: How we ensure transparent conflict of interest disclosure and management.

  13. 27. sij
  14. Perform haematological, cardiovascular, breast and prostatic assessment before the start of testosterone therapy.

  15. 25. sij

    Please join these Poster boards analyzing >900 lymphadenectomies from from an outstanding international collaboration in

  16. Use ipilimumab plus nivolumab in treatment-naïve patients with clear-cell metastatic RCC of IMDC intermediate and poor risk.

  17. Got the exclusive invitation for the EAU Guidelines Cup? Conquer opponents on YUORday at and be named champion! Let the games begin! Check out the info here 👇

  18. 23. sij

    Consensus on controversial points in that we have already incorporated to our ! They will be released at ! Go for them!!

  19. Received the exclusive invitation to join the EAU Guidelines Cup? Show off your skills on YUORday at . You could be this year’s champion! Are you up for the challenge? Details here ▶

  20. 18. sij

    breaking news: Wiegel on new on postoperative

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.